SCHEMBL19901495

SCHEMBL19901495

CCCC(CCC)c1ccc(Br)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.47
ESR2 Q92731 1/20 0.47
PYCR1 P32322 1/20 0.40
KMT2A Q03164 2/20 0.40
HTR2A P28223 1/20 0.39
CYP2A6 P11509 1/20 0.38
CYP1A2 P05177 2/20 0.38
FPR2 P25090 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
ALOX5 P09917 1/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GRIA4 P48058 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19003654 0.92 ESR1 (0.42) ESR1ESR2PYCR1KMT2AHTR2A
SCHEMBL18719647 0.91 ESR1 (0.44) ESR1ESR2PYCR1KMT2AHTR2A
SCHEMBL25788715 0.90 NR1I2 (0.45) ESR1ESR2PYCR1KMT2AHTR2A
SCHEMBL18896204 0.86 NR1I2 (0.41) ESR1ESR2PYCR1HTR2ACYP2A6
SCHEMBL18816268 0.85 NR1I2 (0.47) ESR1ESR2PYCR1HTR2ACYP1A2
SCHEMBL18816275 0.83 NR1I2 (0.50) PYCR1HTR2ACYP1A2CYP2D6SMN1; SMN2
SCHEMBL22358957 0.83 NR1I2 (0.50) PYCR1HTR2ACYP1A2CYP2D6SMN1; SMN2
SCHEMBL19351071 0.83 NR1I2 (0.50) PYCR1HTR2ACYP1A2CYP2D6SMN1; SMN2
SCHEMBL18763953 0.81 NR1I2 (0.49) PYCR1CYP1A2CYP2D6SMN1; SMN2
SCHEMBL18896268 0.81 NR1I2 (0.49) PYCR1CYP1A2CYP2D6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110627831-A Bibiaryl acetal phosphines, their preparation and use in coupling reactions 东莞市均成高新材料有限公司 2019-12-31 CN disclosed
US-9901592-B2 Methods for treating resistant diseases using triazole containing macrolides CEMPRA PHARMACEUTICALS, INC. (US) 2018-02-27 US disclosed